Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016614 |
1-nitronaphthalene |
1-nitronaphthalene metabolite binds to TPM1 protein | affects binding | 16453347
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of TPM1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of TPM1 mRNA | affects expression | 21346803
|
D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [Allylamine results in increased expression of TPM1 mRNA] | decreases reaction|increases expression | 15910882
|
D000499 |
Allylamine |
Acetylcysteine inhibits the reaction [Allylamine results in increased expression of TPM1 mRNA] | decreases reaction|increases expression | 15910882
|
D000499 |
Allylamine |
Allylamine results in increased expression of TPM1 mRNA | increases expression | 15910882
|
D000499 |
Allylamine |
Allylamine results in increased expression of TPM1 protein | increases expression | 15910882
|
D000499 |
Allylamine |
Hydrogen Peroxide inhibits the reaction [Allylamine results in increased expression of TPM1 mRNA] | decreases reaction|increases expression | 15910882
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TPM1 mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of TPM1 protein | decreases expression | 16483693
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of TPM1 mRNA | affects expression | 17331233
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TPM1 mRNA | decreases expression | 19150397
|
C095105 |
bexarotene |
bexarotene results in increased expression of TPM1 mRNA | increases expression | 16648578
|
C006780 |
bisphenol A |
bisphenol A affects the expression of TPM1 mRNA | affects expression | 20170705
|
C032036 |
bromobenzene |
bromobenzene metabolite binds to TPM1 protein | affects binding | 17305373
|
D002104 |
Cadmium |
Cadmium results in decreased expression of TPM1 mRNA | decreases expression | 17327700
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in decreased expression of TPM1 mRNA | decreases expression | 17327700
|
C459604 |
candoxin |
candoxin results in increased expression of TPM1 mRNA | increases expression | 16309724
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of TPM1 mRNA | affects expression | 17484886
|
D002857 |
Chromium |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TPM1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
C057862 |
cyanoginosin LR |
cyanoginosin LR results in increased expression of TPM1 mRNA | increases expression | 17654400
|
D003520 |
Cyclophosphamide |
TPM1 protein affects the susceptibility to Cyclophosphamide | affects response to substance | 16217747
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TPM1 mRNA | affects cotreatment|decreases expression | 16054899
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of TPM1 mRNA | increases expression | 18042831
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of TPM1 mRNA | increases expression | 18597072
|
D004052 |
Diethylnitrosamine |
troglitazone promotes the reaction [Diethylnitrosamine results in increased expression of TPM1 mRNA] | increases expression|increases reaction | 18597072
|
D004317 |
Doxorubicin |
TPM1 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004317 |
Doxorubicin |
[Doxorubicin co-treated with MT2A protein] results in decreased expression of TPM1 protein | affects cotreatment|decreases expression | 16144979
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of TPM1 protein | decreases expression | 16144979
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of TPM1 mRNA | affects expression | 20170705
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of TPM1 mRNA | affects expression | 20170705
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of TPM1 mRNA | increases expression | 12655037
|
D005472 |
Fluorouracil |
TPM1 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
C056933 |
fumonisin B1 |
fumonisin B1 results in increased expression of TPM1 mRNA | increases expression | 16221962
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide inhibits the reaction [Allylamine results in increased expression of TPM1 mRNA] | decreases reaction|increases expression | 15910882
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TPM1 mRNA | affects cotreatment|decreases expression | 16054899
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of TPM1 mRNA | increases expression | 18548127
|
D008942 |
Mitoxantrone |
TPM1 protein affects the susceptibility to Mitoxantrone | affects response to substance | 16217747
|
C016599 |
mono-(2-ethylhexyl)phthalate |
mono-(2-ethylhexyl)phthalate results in increased expression of TPM1 mRNA | increases expression | 16809437
|
C031721 |
naphthalene |
naphthalene metabolite binds to TPM1 protein | affects binding | 16453347
|
C031721 |
naphthalene |
naphthalene metabolite binds to TPM1 protein | affects binding | 15892573
|
D009525 |
Niacin |
LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TPM1 mRNA] | affects binding|increases expression|increases reaction | 16940432
|
C041786 |
palm oil |
palm oil results in increased expression of TPM1 mRNA | increases expression | 18042831
|
D010795 |
Phthalic Acids |
Phthalic Acids results in increased expression of TPM1 mRNA | increases expression | 15728792
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of TPM1 mRNA | decreases expression | 17426115
|
D011374 |
Progesterone |
Progesterone results in decreased expression of TPM1 mRNA | decreases expression | 18037150
|
D011794 |
Quercetin |
Quercetin results in decreased expression of TPM1 mRNA | decreases expression | 18095365
|
D020849 |
Raloxifene |
Raloxifene affects the expression of TPM1 mRNA | affects expression | 14699072
|
D020849 |
Raloxifene |
Raloxifene affects the expression of TPM1 mRNA | affects expression | 16079270
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TPM1 mRNA | affects cotreatment|decreases expression | 16054899
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of TPM1 mRNA | affects expression | 14699072
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of TPM1 mRNA | affects binding|increases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TPM1 mRNA | increases expression | 18796159
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of TPM1 mRNA | decreases expression | 18796159
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TPM1 protein | increases expression | 19201780
|
D019772 |
Topotecan |
TPM1 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
D014212 |
Tretinoin |
Tretinoin affects the expression of TPM1 protein | affects expression | 15789344
|
C057693 |
troglitazone |
troglitazone promotes the reaction [Diethylnitrosamine results in increased expression of TPM1 mRNA] | increases expression|increases reaction | 18597072
|
D014520 |
Urethane |
Urethane results in decreased expression of TPM1 mRNA | decreases expression | 16289808
|
C034028 |
vanadyl sulfate |
vanadyl sulfate results in decreased expression of TPM1 mRNA | decreases expression | 16330358
|
C025643 |
vinclozolin |
vinclozolin affects the expression of TPM1 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.04 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.36 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.06 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.43 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
1-nitronaphthalene |
8.04 | 15204773 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.04 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
8.98 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
8.98 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
8.98 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
8.98 | 18316556 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
5.20 | 15814487 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.11 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Urethane |
6.11 | 17093202 16926031 17195641 6695378 11497255 10822126 10530776 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
14.40 | 19061943 17620307 19052882 17162532 18056438 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
14.40 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
14.40 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
9.89 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
9.89 | 17308373 17451421 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.22 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
4.07 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
4.07 | 19621015 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.25 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.25 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.79 | 17084956 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.24 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
14.26 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
14.26 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
14.26 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
10.42 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
10.42 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
10.42 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.13 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.18 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.48 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.34 | 15687053 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Phthalic Acids |
4.02 | 20106747 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
3.92 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.93 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
12.69 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
12.69 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
12.69 | 16197459 16206674 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.28 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.43 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.19 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.42 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.83 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
9.35 | 15665606 15380490 15845082 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
9.35 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.38 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
11.64 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
11.64 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Chromium |
11.64 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
11.64 | 12006526 17020986 18234424 15136595 11325840 16978400 17388661 15093573 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
11.64 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
11.64 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
11.64 | 16115903 15994142 16096432 15939500 19526202 15668708 18628466 15567936 17369602 18695136 11325840 16322301 17983394 15634643 15692762 16826403 18234424 15136595 17426702 15993339 16595493 18382427 16264153 16935488 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
11.64 | 16110121 16595493 18608205 19217205 15136595 18357371 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
11.64 | 17614352 16175315 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
11.64 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
11.64 | 17952589 17893378 17261762 15775269 16837676 15572757 16912660 15758505 17440819 17595753 17242785 17049068 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
11.64 | 19200415 16818667 19084267 18629630 19410462 15668708 21138602 19155303 19011961 20005174 17440819 17893378 17261762 19142967 20390343 18984771 19288272 18815881 16873071 19189210 21152245 16202921 20859285 19103187 17049068 15565566 19487384 16273361 18425577 20544844 19059307 18821012 11161223 18351453 17242785 18997820 19066611 18855134 19115204 20065188 19244106 20135344 19189212 19221464 19289846 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
11.64 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
11.64 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.09 | 16813970 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.04 | 16962696 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.30 | 3786805 16097048 15700767 16011737 16227642 16124888 15673190 18705752 16192424 10355542 16050911 15721981 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
10.66 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
10.66 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
6.87 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.87 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.02 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.65 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
20.70 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
20.70 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
20.70 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
20.70 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
20.70 | 16681979 16540662 20727157 20084675 18788625 20524982 16935385 3581430 20214788 19822196 19208518 20512989 18691550 3084413 20432363 18210153 16878318 19701751 18056438 16830150 10737359 19418558 19919837 18494052 10672840 21159647 16569478 18978308 16328049 18506893 17055752 19335982 20514400 19519916 16502159 19052882 11831363 16807293 20935162 18971187 17978847 18393292 20101231 17173139 17428255 17162532 18785209 16779866 19107877 19383236 19171122 17138121 17761372 16698587 19539802 20007298 19394651 18665156 16288022 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
20.70 | 18059187 16234567 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
20.70 | 16799960 17045692 18930000 16332177 17971768 17088986 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
20.70 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
20.70 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
20.70 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.49 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.39 | 16152834 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.04 | 16247446 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.47 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
9.42 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
9.42 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
9.42 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
9.44 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
9.44 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
9.44 | 18986760 17066447 16757204 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
9.44 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.06 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.06 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
5.83 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
5.83 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.19 | 15792986 17308081 17974986 17007740 17382496 16364871 17924179 16651473 16269455 18627295 16278810 17329180 15811867 16109756 16731534 15505089 16952015 17131338 17928571 17519947 16455267 17351982 15476868 16612575 16242529 |
MESH:D002311 |
Cardiomyopathy, Dilated |
marker/mechanism |
|
| |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.76 | 17334414 16243910 |
OMIM:115196 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3 |
marker/mechanism |
|
| |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
6.41 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.41 | 15775269 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.79 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
17.40 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
17.40 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
17.40 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
17.40 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
17.40 | 21159647 7505956 17174075 2727394 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.09 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.93 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.93 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.50 | 11677210 16919318 16105132 15861022 17681005 17110522 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.50 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.65 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
8.58 | 8697196 15340226 16354765 15668235 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
8.58 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
8.58 | 12810352 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.13 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.22 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
5.23 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.23 | 17018589 17725105 17287894 15001691 16340194 18772588 17172411 16510598 17169374 17016597 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
5.23 | 19056647 19440933 17191121 16640504 15741050 17148506 11134977 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.20 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.20 | 17094418 18802399 14970324 16524972 18383874 20501625 18448328 17695437 18509181 16282729 17401013 16391804 17255274 17016601 16331619 17594712 18949393 16303861 18288408 15289873 15148649 17454858 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.20 | 18095365 18852136 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.64 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
3.43 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.43 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.43 | 8800419 9211117 17551590 9125849 10589399 9664655 14991402 9142499 9224671 16925845 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
3.87 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
9.28 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
9.28 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
3.95 | 19747007 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.48 | 18372110 12913760 16614059 18295254 11948286 10700343 16989017 16413132 15276878 12388444 10498854 12161096 18483878 17979934 18710439 15643279 16651033 18433785 17010015 18093676 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.29 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.88 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.74 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
2.95 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.18 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
3.88 | 17446233 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
11.79 | 15331540 11751995 10990075 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
11.79 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
11.79 | 16684804 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.05 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
9.08 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
9.08 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
9.08 | 17107852 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
troglitazone |
9.08 | 16023994 |
MESH:D003925 |
Diabetic Angiopathies |
|
troglitazone |
5.15 | 12601628 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
7.64 | 17451421 17308373 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
7.64 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.01 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.24 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
1-nitronaphthalene |
33.02 | 8212003 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
33.02 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
33.02 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
33.02 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bromobenzene |
33.02 | 10092053 12628495 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
33.02 | 15998439 6884620 3732212 7440962 6623471 10915739 11566570 21278145 9327722 16227642 3786805 10092053 19336974 2869522 7120509 15027814 4309450 16177239 15968718 7179309 17522070 19085960 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
cyanoginosin LR |
33.02 | 17654400 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
33.02 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
33.02 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
33.02 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
33.02 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
troglitazone |
33.02 | 14986274 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
6.87 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
6.87 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.09 | 18367378 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.99 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
16.99 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
16.99 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
16.99 | 15860553 |
MESH:D004487 |
Edema |
|
rosiglitazone |
16.99 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
16.99 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.25 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.25 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
18.06 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
18.06 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
18.06 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
18.06 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
10.54 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
10.54 | 16202921 17893378 19155303 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
10.54 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.49 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.49 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.65 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.74 | 11006010 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.61 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.00 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.00 | 16481741 16785472 15173087 17638652 16337965 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.59 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.59 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
35.53 | 16239168 19224547 15959796 12631006 17595544 61145 12795759 16045604 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
35.53 | 18296743 17967931 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
35.53 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
35.53 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
35.53 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
35.53 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
35.53 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
35.53 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.92 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.97 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.03 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
9.79 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
9.79 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
22.60 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
22.60 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
22.60 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
22.60 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
22.60 | 17994277 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.44 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.79 | 16417039 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
10.00 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
10.00 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
10.00 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
5.45 | 16145905 |
MESH:D005910 |
Glioma |
|
Quercetin |
5.45 | 17643826 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.02 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.09 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.55 | 15172196 16376943 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
10.98 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
10.98 | 18337622 15162350 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
10.98 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.65 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.60 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.60 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
15.29 | 18006777 12587719 17875725 16244371 17888722 18674790 14766674 16707910 16144979 16495754 16330681 16879835 16244372 |
MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
15.29 | 16019553 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
15.29 | 11110106 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
15.29 | 16046796 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
5.99 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
5.99 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.46 | 15692506 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.80 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.89 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.03 | 14986274 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.13 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
11.69 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
11.69 | 19176532 16221962 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
11.69 | 16120746 12621046 15340226 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.88 | 7520565 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
6.34 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
6.34 | 15147373 18501091 17606976 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.54 | 18606429 16354765 15340226 16959395 8697196 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
6.76 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.76 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.03 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.15 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.08 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
7.81 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
7.81 | 18262572 11834736 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.16 | 21332399 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
10.65 | 17042910 |
MESH:D006973 |
Hypertension |
|
Quercetin |
10.65 | 18356687 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
10.65 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
10.65 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.60 | 15338365 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.32 | 16569931 16945680 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
4.94 | 18306037 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.82 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
3.92 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.00 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
9.31 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
9.31 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
9.31 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
19.97 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
19.97 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
19.97 | 18785209 |
MESH:D007249 |
Inflammation |
|
Progesterone |
19.97 | 15869954 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
19.97 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
19.97 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
19.97 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
4.00 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
14.92 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
14.92 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
14.92 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
14.92 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.28 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.45 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.45 | 15992940 17551590 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
4.94 | 18306037 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.47 | 17086741 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
15.91 | 16226777 16322080 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
15.91 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Chromium |
15.91 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
15.91 | 15699352 15369732 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
15.91 | 16962696 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.64 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
8.64 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
14.45 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
14.45 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
14.45 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
14.45 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.04 | 16973256 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
9.05 | 10602166 |
MESH:D007938 |
Leukemia |
|
Quercetin |
9.05 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
9.05 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
12.54 | 16085563 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
troglitazone |
12.54 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
6.20 | 17008537 17658394 17296974 17802794 18587576 18172266 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
6.20 | 18172266 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.72 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.26 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
1.98 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.82 | 17506722 17361223 12679006 15748426 19075265 16331271 19029980 17217047 16891316 19642359 19225113 17339181 16935935 16140955 17301526 17368321 17294898 16766008 16823087 19035177 16788101 17107899 9834237 17649720 17712046 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.47 | 10052129 11830472 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.23 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.95 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.80 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
9.32 | 17334410 11408273 17174718 11903743 16221502 17157831 16239168 16943688 21278145 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
9.32 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
9.32 | 19638242 18522880 18407596 18665156 20032147 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
14.08 | 15730626 12586293 16248980 18006644 12632512 18472332 15818738 18339082 18210741 16033810 13678700 18277467 17714472 20821823 17761835 17976157 17557913 12666154 15338365 16015684 18412020 15893842 17708605 15876570 16192424 16011737 18395914 17922224 12958196 18054572 17631135 12649538 15673190 16027843 12898905 18420326 12632514 15362042 17766677 15996030 18376398 12741479 18251166 18395095 18187930 15370692 17805973 18481824 12546737 12609069 12445421 15925388 17640975 15931870 17481882 17698563 17565644 14748882 17823541 18263696 16136751 16638106 18705752 11481614 16116963 18279442 18429990 17944888 18156304 10355542 17721639 15052691 18317297 12445418 14716833 15123356 18205269 18472094 15650968 17869086 14724832 14716496 14620537 15959796 18166357 16097048 17525996 17900296 15057751 14512876 12667390 12389079 18418968 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
14.08 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
14.08 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
14.08 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
14.08 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
14.08 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
14.08 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
14.08 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
14.08 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.57 | 16246199 15830285 16964402 17285989 15720792 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.57 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.68 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.26 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
25.88 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
25.88 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
25.88 | 20434301 20118626 19499222 20101389 18644402 18648771 9163691 21071580 19256749 20501860 19690152 18978307 12771043 19254457 19551842 15175105 21047994 19294768 19996281 18977376 19255062 19642983 21278145 2862719 2422723 19426721 20405173 10737359 20492335 19073162 20583210 21167192 15885732 19090486 18754104 20137499 19833225 19812893 19427195 19638242 16942905 12112319 20452335 19850985 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
25.88 | 18383874 15113037 17045692 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
25.88 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
25.88 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
25.88 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
25.88 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
25.88 | 16391232 17093202 17559639 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
19.18 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
19.18 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
19.18 | 16267830 17854601 19009564 18079962 9362446 16842330 19519916 2563599 19004024 3124819 17174075 18544905 19539802 17942915 18282651 18093689 18164116 18253720 18775883 21159647 18308698 19126423 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
19.18 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
19.18 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
19.18 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
1-nitronaphthalene |
7.28 | 8212003 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
7.28 | 12815614 |
MESH:D055370 |
Lung Injury |
|
1-nitronaphthalene |
12.80 | 2384072 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
12.80 | 17365036 |
MESH:D055370 |
Lung Injury |
|
naphthalene |
12.80 | 6834280 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
13.81 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
13.81 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
13.81 | 20512841 20970405 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
13.81 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
13.81 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
13.81 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
13.81 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
13.81 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
13.81 | 11246140 6695378 10997738 11893704 11497255 12957351 11062179 15902970 11074608 10822126 10530776 12466968 12117781 11544531 16204055 16289808 16337739 16391232 7750092 15166089 17255336 11307925 11552296 14587096 17093202 16007126 10779650 11323394 17195641 16788158 11807781 16926031 11992545 15136453 12765245 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.29 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
6.68 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
6.68 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.14 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
7.64 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
7.64 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.08 | 15621674 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.66 | 11161223 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.27 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
15.34 | 19196722 15591091 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
15.34 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
15.34 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
15.34 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
15.34 | 11731420 16827153 19196722 19196723 14580682 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.04 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.57 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
4.49 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.49 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.49 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.68 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.32 | 16388313 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.94 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
5.70 | 16966607 16166281 18303189 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
5.70 | 17638057 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
3.97 | 17261469 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.05 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.05 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.25 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.29 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
6.36 | 16118317 15867202 15744524 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
6.36 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.02 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
6.54 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.54 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
8.16 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.16 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
8.16 | 19595682 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.62 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.16 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
7.16 | 19207477 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.05 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
8.69 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
8.69 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
11.80 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
11.80 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
11.80 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
11.80 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.34 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
19.95 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
19.95 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
19.95 | 16640825 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
19.95 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
19.95 | 15185748 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
19.95 | 16594593 16946489 |
MESH:D009369 |
Neoplasms |
|
Urethane |
19.95 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
4.20 | 15582191 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
9.25 | 19196722 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
9.25 | 19189210 19196722 19200415 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.28 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.58 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
13.64 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
13.64 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
13.64 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
6.52 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.52 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
10.01 | 16115947 8761367 15176712 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
10.01 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
10.01 | 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
2.94 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.39 | 8761367 12837982 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
3.90 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.61 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.09 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
3.87 | 8291058 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
3.94 | 20518802 17217161 11836018 19632207 18674790 21332399 20132043 16723640 18457598 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.94 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
7.45 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
7.45 | 16049721 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.22 | 16517039 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.08 | 19059307 17882678 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
8.67 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
8.67 | 15579764 17893378 17823083 15758505 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.72 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.49 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
9.85 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
9.85 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
9.85 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
9.85 | 16391232 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
5.72 | 12161096 18093676 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.72 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
14.15 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
14.15 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
14.15 | 19003803 16929163 15113037 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
14.15 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
14.15 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.23 | 11578682 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.61 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.74 | 12520081 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
4.88 | 15687053 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.65 | 17983394 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
4.93 | 16391232 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.41 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.65 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.09 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
7.83 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
7.83 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
6.83 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
6.83 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
13.38 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
13.38 | 11399792 11222880 11896295 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
13.38 | 19015723 18042343 18220299 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.44 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
3.76 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.73 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.73 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.73 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.73 | 16888761 15897917 15749863 18437689 16868541 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.73 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.73 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
2.73 | 14715546 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.73 | 16536755 15731164 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.73 | 15067354 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.44 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.15 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.82 | 16919318 15861022 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.29 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.29 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
8.29 | 17975199 17322281 15814490 17365031 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
8.29 | 16636934 |
MESH:D011658 |
Pulmonary Fibrosis |
|
troglitazone |
8.29 | 18162602 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.05 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.59 | 18722050 18286688 16160472 15538739 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.74 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.13 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
7.97 | 12210543 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
7.97 | 11700416 18379247 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.64 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.66 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.56 | 17710206 15675481 16767912 17203757 15625365 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.77 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.29 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.04 | 16862918 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.36 | 16636934 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
4.73 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
4.73 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
15.23 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
15.23 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
15.23 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
15.23 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
15.23 | 11807781 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.08 | 16767912 17203757 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
9.87 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
9.87 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.02 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
9.22 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
9.22 | 19457130 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.83 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.27 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
4.27 | 18567086 16424979 18396642 16951190 17522103 15786421 17172411 19015929 19084572 17498489 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.27 | 17261132 |
MESH:D013274 |
Stomach Neoplasms |
|
troglitazone |
4.27 | 15930296 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
6.27 | 17918041 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
6.27 | 15138204 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.43 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.49 | 16045194 16684133 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.56 | 12837982 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.16 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.73 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.39 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
9.81 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
9.81 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
9.81 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
4.70 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
8.39 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.39 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.91 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
20.77 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
20.77 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
20.77 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
20.77 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
20.77 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
20.77 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
20.77 | 8653321 17572228 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
10.33 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
10.33 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
8.01 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.01 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.50 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.83 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.10 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.31 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.09 | 12125929 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
5.40 | 10620525 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.70 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.09 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.74 | 17638931 17334414 17678736 16364871 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.58 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.05 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.74 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.32 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.55 | 16287080 |